Needham analyst Mayank Tandon lowered the firm’s price target on Genpact (G) to $50 from $53 and keeps a Buy rating on the shares. The company posted solid Q4 results, beating estimates on the top and bottom line, driven primarily by its Advanced Technology Solutions segment, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on G:
- Genpact: AI-Led Growth, Margin Durability, and Strong 2026 Visibility Support Buy Rating
- Genpact sees FY26 net revenue growth ‘at least’ 7% on reported basis
- Genpact reports Q4 adjusted EPS 97c, consensus 93c
- Genpact raises quarterly dividend 10% to 18.75c per share
- Genpact sees Q1 adjusted EPS 92c-93c, consensus 92c